BASKING RIDGE, N.J. & RAHWAY, N.J., May 19, 2025--(BUSINESS WIRE)--The first patient has been dosed in the IDeate-Esophageal01 phase 3 trial evaluating the efficacy and safety of investigational ...
For local founder Rahmi Halaby, launching his company’s product to the public is the catalyst for its next phase of growth. Halaby’s company, Ideate, officially launched its first product — a platform ...
BASKING RIDGE, N.J. & RAHWAY, N.J.--(BUSINESS WIRE)--The first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab deruxtecan ...
The first patient has been dosed in the IDeate-Prostate01 phase 3 clinical trial to evaluate the efficacy and safety of investigational ifinatamab deruxtecan (I-DXd) versus docetaxel in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback